Abstract
Substance use of disorders--including alcohol, cocaine, and opiod dependencies--are common in HIV-infected patients. Untreated substance use disorders result in poor HIV disease treatment outcomes; however, several new treatment strategies have emerged in recent years. Combined medication and counseling therapies are effective for alcohol and opioid dependencies, and counseling treatments are effective for cocaine dependence. Office-based treatment with buprenorphine offers the opportunity for coordinated treatment of HIV disease and opioid dependence. This article summarizes a presentation by David A. Fiellin, MD, in March 2004 at the International AIDS Society-USA New York course.
MeSH terms
-
Alcohol-Related Disorders
-
Anti-HIV Agents / therapeutic use
-
Cocaine-Related Disorders / diagnosis
-
Cocaine-Related Disorders / drug therapy
-
Cocaine-Related Disorders / epidemiology
-
Female
-
Follow-Up Studies
-
HIV Infections / diagnosis
-
HIV Infections / drug therapy*
-
HIV Infections / epidemiology*
-
Humans
-
Incidence
-
Male
-
Narcotic Antagonists / therapeutic use
-
Opioid-Related Disorders / diagnosis
-
Opioid-Related Disorders / drug therapy
-
Opioid-Related Disorders / epidemiology
-
Patient Compliance
-
Risk Assessment
-
Severity of Illness Index
-
Substance-Related Disorders / diagnosis
-
Substance-Related Disorders / drug therapy*
-
Substance-Related Disorders / epidemiology*
-
Treatment Outcome
Substances
-
Anti-HIV Agents
-
Narcotic Antagonists